267 related articles for article (PubMed ID: 27920668)
21. Delivery of MicroRNAs by Chitosan Nanoparticles to Functionally Alter Macrophage Cholesterol Efflux in Vitro and in Vivo.
Nguyen MA; Wyatt H; Susser L; Geoffrion M; Rasheed A; Duchez AC; Cottee ML; Afolayan E; Farah E; Kahiel Z; Côté M; Gadde S; Rayner KJ
ACS Nano; 2019 Jun; 13(6):6491-6505. PubMed ID: 31125197
[TBL] [Abstract][Full Text] [Related]
22. miR-10b-5p expression in Huntington's disease brain relates to age of onset and the extent of striatal involvement.
Hoss AG; Labadorf A; Latourelle JC; Kartha VK; Hadzi TC; Gusella JF; MacDonald ME; Chen JF; Akbarian S; Weng Z; Vonsattel JP; Myers RH
BMC Med Genomics; 2015 Mar; 8():10. PubMed ID: 25889241
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-targeted therapeutics for lung cancer treatment.
Xue J; Yang J; Luo M; Cho WC; Liu X
Expert Opin Drug Discov; 2017 Feb; 12(2):141-157. PubMed ID: 27866431
[TBL] [Abstract][Full Text] [Related]
24. Shared Molecular Pathways in Glaucoma and Other Neurodegenerative Diseases: Insights from RNA-Seq Analysis and miRNA Regulation for Promising Therapeutic Avenues.
Vasconcelos CFM; Ribas VT; Petrs-Silva H
Cells; 2023 Aug; 12(17):. PubMed ID: 37681887
[TBL] [Abstract][Full Text] [Related]
25. MicroRNAs in Alzheimer's Disease: Diagnostic Markers or Therapeutic Agents?
Angelucci F; Cechova K; Valis M; Kuca K; Zhang B; Hort J
Front Pharmacol; 2019; 10():665. PubMed ID: 31275145
[TBL] [Abstract][Full Text] [Related]
26. Liver as a target for oligonucleotide therapeutics.
Sehgal A; Vaishnaw A; Fitzgerald K
J Hepatol; 2013 Dec; 59(6):1354-9. PubMed ID: 23770039
[TBL] [Abstract][Full Text] [Related]
27. Recent Advances in miRNA Delivery Systems.
Dasgupta I; Chatterjee A
Methods Protoc; 2021 Jan; 4(1):. PubMed ID: 33498244
[TBL] [Abstract][Full Text] [Related]
28. Aberration of miRNAs Expression in Leukocytes from Sporadic Amyotrophic Lateral Sclerosis.
Chen Y; Wei Q; Chen X; Li C; Cao B; Ou R; Hadano S; Shang HF
Front Mol Neurosci; 2016; 9():69. PubMed ID: 27582688
[TBL] [Abstract][Full Text] [Related]
29. miRNA and cancer; computational and experimental approaches.
Tutar Y
Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
[TBL] [Abstract][Full Text] [Related]
30. Gene networks in neurodegenerative disorders.
Recabarren D; Alarcón M
Life Sci; 2017 Aug; 183():83-97. PubMed ID: 28623007
[TBL] [Abstract][Full Text] [Related]
31. Abnormalities of Mitochondrial Dynamics in Neurodegenerative Diseases.
Gao J; Wang L; Liu J; Xie F; Su B; Wang X
Antioxidants (Basel); 2017 Apr; 6(2):. PubMed ID: 28379197
[TBL] [Abstract][Full Text] [Related]
32. Delivery of therapeutic miRNA using polymer-based formulation.
Ban E; Kwon TH; Kim A
Drug Deliv Transl Res; 2019 Dec; 9(6):1043-1056. PubMed ID: 31049843
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA biomarkers as next-generation diagnostic tools for neurodegenerative diseases: a comprehensive review.
Azam HMH; Rößling RI; Geithe C; Khan MM; Dinter F; Hanack K; Prüß H; Husse B; Roggenbuck D; Schierack P; Rödiger S
Front Mol Neurosci; 2024; 17():1386735. PubMed ID: 38883980
[TBL] [Abstract][Full Text] [Related]
34. Advances in the treatment of neurodegenerative disorders employing nanoparticles.
Spuch C; Saida O; Navarro C
Recent Pat Drug Deliv Formul; 2012 Apr; 6(1):2-18. PubMed ID: 22272933
[TBL] [Abstract][Full Text] [Related]
35. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
36. Copper dyshomoeostasis in Parkinson's disease: implications for pathogenesis and indications for novel therapeutics.
Davies KM; Mercer JF; Chen N; Double KL
Clin Sci (Lond); 2016 Apr; 130(8):565-74. PubMed ID: 26957644
[TBL] [Abstract][Full Text] [Related]
37. Panoramic Visualization of Circulating MicroRNAs Across Neurodegenerative Diseases in Humans.
Brennan S; Keon M; Liu B; Su Z; Saksena NK
Mol Neurobiol; 2019 Nov; 56(11):7380-7407. PubMed ID: 31037649
[TBL] [Abstract][Full Text] [Related]
38. Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys.
Cho IK; Yang B; Forest C; Qian L; Chan AWS
PLoS One; 2019; 14(3):e0214156. PubMed ID: 30897183
[TBL] [Abstract][Full Text] [Related]
39. Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases.
Barchet TM; Amiji MM
Expert Opin Drug Deliv; 2009 Mar; 6(3):211-25. PubMed ID: 19290842
[TBL] [Abstract][Full Text] [Related]
40. Computational and in vitro Investigation of miRNA-Gene Regulations in Retinoblastoma Pathogenesis: miRNA Mimics Strategy.
Venkatesan N; Deepa PR; Khetan V; Krishnakumar S
Bioinform Biol Insights; 2015; 9():89-101. PubMed ID: 25983556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]